It’s a derisking moment. If the Azer-Cel trials were to fail we’ve already got our money back and we are off the hook.
If they are a big success, we’ve got our supply lines sorted. And the cost of goods will be insignificant once the drugs hit the market. Probably around $3-$400k patient for The first indication. Seriously big money.
Once the first 10 cohort in the confirmation trial is successful, this is ready to licence or sell off.
- Forums
- ASX - By Stock
- IMU
- Ann: Imugene & Kincell Bio Strategic Partnership Investor Webinar
Ann: Imugene & Kincell Bio Strategic Partnership Investor Webinar, page-10
-
-
- There are more pages in this discussion • 42 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $364.4M |
Open | High | Low | Value | Volume |
5.0¢ | 5.1¢ | 4.9¢ | $417.0K | 8.344M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
34 | 4029429 | 4.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.0¢ | 1152429 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
33 | 3979429 | 0.049 |
40 | 8720346 | 0.048 |
37 | 3904669 | 0.047 |
25 | 1927676 | 0.046 |
38 | 4232798 | 0.045 |
Price($) | Vol. | No. |
---|---|---|
0.050 | 1152429 | 3 |
0.051 | 4283549 | 13 |
0.052 | 1749634 | 7 |
0.053 | 820232 | 9 |
0.054 | 2036787 | 12 |
Last trade - 16.10pm 25/09/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |
The Watchlist
BPH
BPH ENERGY LTD
David Breeze, Managing Director and Executive Chairman
David Breeze
Managing Director and Executive Chairman
SPONSORED BY The Market Online